Myostin Therapeutics Limited is a limited by shares, unlisted public company, Australian public company. This corporation was registered on 2008-09-09 and was issued with the 133150884 ACN. Its Australian Business Number is 20133150884. Since 2023-07-18, the company is headquartered in NSW, post code 2535. The previous headquarters were located in VIC 3053 (from 2021-09-20 to 2023-07-18), VIC 3187 (from 2016-05-18 to 2021-09-20), and VIC 3187 (from 2014-09-10 to 2016-05-18). Myostin Therapeutics Limited was registered for the GST on 2008-10-01. Myostin Therapeutics Limited has been using the Mdx Biotech trading name since 2008-10-01 until 2011-04-07 (it needs to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2023-07-19.
| Status | From | To |
|---|---|---|
| Active | Wed, 1st Oct 2008 | current |
| Name | From | To |
|---|---|---|
| Myopharm Limited | Sat, 10th Oct 2020 | current |
| Myostin Therapeutics Pty Ltd | Wed, 30th Mar 2011 | Sat, 10th Oct 2020 |
| Mdx Biotech Pty Ltd | Wed, 1st Oct 2008 | Wed, 30th Mar 2011 |
| Name | From | To |
|---|---|---|
| Mdx Biotech | Wed, 1st Oct 2008 | Thu, 7th Apr 2011 |
| Location | From | To |
|---|---|---|
| NSW 2535 | Tue, 18th Jul 2023 | current |
| VIC 3053 | Mon, 20th Sep 2021 | Tue, 18th Jul 2023 |
| VIC 3187 | Wed, 18th May 2016 | Mon, 20th Sep 2021 |
| VIC 3187 | Wed, 10th Sep 2014 | Wed, 18th May 2016 |
| VIC 3187 | Wed, 1st Oct 2008 | Wed, 10th Sep 2014 |
| Status | From | To |
|---|---|---|
| Registered | Wed, 1st Oct 2008 | current |
Advertisements
General information:
| Patent status: |
Filed The specification prior to acceptance and where the application has not lapsed |
| Patent type: | STANDARD |
International Patent Classification:
| IPC Mark: | A61K 38/18 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
| Main group code: | 38 - medicinal preparations containing peptides (peptides containing beta-lactam rings a61k0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, a61k0031000000; ergoline-based peptides a61k0031480000; containing macromolecular compounds having statistically distributed amino acid units a61k0031740000; medicinal preparations containing antigens or antibodies a61k0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, a61k0047000000) |
| Subgroup code: | 18 - growth factors; growth regulators |
IP Australia process information:
| Expiry date: | Mon, 2nd Aug 2027 |
General information:
| Patent status: |
Filed The specification prior to acceptance and where the application has not lapsed |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61P 17/00 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
| Main group code: | 17 - drugs for dermatological disorders |
IP Australia process information:
| Expiry date: | Sun, 29th Sep 2030 |
General information:
| Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | C07K 19/00 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 7 - organic chemistry |
| Subclass code: | K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000) |
| Main group code: | 19 - hybrid peptides (hybrid immunoglobulins composedsolely of immunoglobulins c07k0016460000) |
IP Australia process information:
| Expiry date: | Mon, 2nd Aug 2027 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.